hyperuricemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) It met the diagnostic criteria of HUA and did not cause joint inflammation. 2) meeting the diagnostic criteria of spleen deficiency and dampness; 3) patients with hypertension abnormal lipid metabolism diabetes obesity coronary heart disease and other comorbidities and serum uric acid level =480µmol/L or patients with serum uric acid level =540µmol/L; 4)18 to 65 years old male or female; (5) no drugs that could affect the observation of the study were used in the 15 days before enrollment; 6) Consent to sign the informed consent.
Exclusion criteria
Exclusion criteria: 1) History of acute gout attack renal calculi tophi formation uric acid nephropathy and other complications; 2) Suspicious secondary hyperuricemia such as blood disease kidney disease tumor radiotherapy and chemotherapy or taking related drugs Viremia; 3) patients with severe heart liver and kidney diseases; 4) pregnant or lactating patients; 5) drug contraindications and allergies; 6) participated in other clinical trials in the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood uric acid control rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The fluctuation of blood uric acid;The average dosage of allopurinol tablets; Chinese medicine symptom complex score;The time of the first acute gout attack;Conversion rate of gout;The number of gout attacks; | — |
Countries
China
Contacts
The Third People's Hospital affiliated to Fujian University of Traditional Chinese Medicine